![](/images/general/no_picture/200_user.png)
Viet Q Nguyen
Examiner (ID: 17436, Phone: (571)272-1788 , Office: P/2827 )
Most Active Art Unit | 2827 |
Art Unit(s) | 2511, 2503, 2827, 2307, 2818, 2824 |
Total Applications | 3785 |
Issued Applications | 3430 |
Pending Applications | 119 |
Abandoned Applications | 236 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16312329
[patent_doc_number] => 20200291067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => IL-2RGAMMA BINDING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/884726
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 110917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884726
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/884726 | IL-2Rgamma binding compounds | May 26, 2020 | Issued |
Array
(
[id] => 16312328
[patent_doc_number] => 20200291066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => IL-2RBETA BINDING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/884661
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 111098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884661
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/884661 | IL-2RBETA binding compounds | May 26, 2020 | Issued |
Array
(
[id] => 17242004
[patent_doc_number] => 20210361747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => RECOMBINANT THROMBOMODULIN DOMAIN 1 FOR USE IN TREATING EYE DISEASES ASSOCIATED WITH PATHOLOGICAL OCULAR ANGIOGENESIS
[patent_app_type] => utility
[patent_app_number] => 16/882508
[patent_app_country] => US
[patent_app_date] => 2020-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16882508
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/882508 | Recombinant thrombomodulin domain 1 for use in treating eye diseases associated with pathological ocular angiogenesis | May 23, 2020 | Issued |
Array
(
[id] => 16598060
[patent_doc_number] => 20210024591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => TARGETING G3BP AGGREGATION TO PREVENT NEURODEGENERATION
[patent_app_type] => utility
[patent_app_number] => 16/881096
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16881096
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/881096 | Targeting G3BP aggregation to prevent neurodegeneration | May 21, 2020 | Issued |
Array
(
[id] => 16762361
[patent_doc_number] => 20210107942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE
[patent_app_type] => utility
[patent_app_number] => 16/878318
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878318
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878318 | TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED WITH TISSUE DAMAGE | May 18, 2020 | Abandoned |
Array
(
[id] => 17618985
[patent_doc_number] => 11338012
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => BRAF-based polypeptides for treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 15/930660
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 27
[patent_no_of_words] => 13134
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930660
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930660 | BRAF-based polypeptides for treatment of cancer | May 12, 2020 | Issued |
Array
(
[id] => 16391025
[patent_doc_number] => 20200331966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => FUSION PROTEIN COMPOSITION(S) COMPRISING MASKED TYPE I INTERFERONS (IFNA AND IFNB) FOR USE IN THE TREATMENT OF CANCER AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/849889
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849889 | Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof | Apr 14, 2020 | Issued |
Array
(
[id] => 16599342
[patent_doc_number] => 20210025873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => METHODS OF IDENTIFYING AND MONITORING MITOCHONDRIAL DYSFUNCTION USING MONOCYTE SCREENING
[patent_app_type] => utility
[patent_app_number] => 16/845687
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845687
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/845687 | Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening | Apr 9, 2020 | Issued |
Array
(
[id] => 16598386
[patent_doc_number] => 20210024917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => Methods for Enhancing Bacterial Cell Display of Proteins and Peptides
[patent_app_type] => utility
[patent_app_number] => 16/843329
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843329
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843329 | Methods for Enhancing Bacterial Cell Display of Proteins and Peptides | Apr 7, 2020 | Abandoned |
Array
(
[id] => 17134828
[patent_doc_number] => 11136374
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Polypeptides and medical uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/839155
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 38
[patent_no_of_words] => 20729
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839155
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/839155 | Polypeptides and medical uses thereof | Apr 2, 2020 | Issued |
Array
(
[id] => 17362671
[patent_doc_number] => 11229679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-25
[patent_title] => Compositions for treating heart disease by inhibiting the action of mAKAPb
[patent_app_type] => utility
[patent_app_number] => 16/837633
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 47
[patent_no_of_words] => 23707
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16837633
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/837633 | Compositions for treating heart disease by inhibiting the action of mAKAPb | Mar 31, 2020 | Issued |
Array
(
[id] => 17680045
[patent_doc_number] => 11364276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Antiviral peptides for treatment of the middle east respiratory syndrome
[patent_app_type] => utility
[patent_app_number] => 16/831187
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 15031
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16831187
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/831187 | Antiviral peptides for treatment of the middle east respiratory syndrome | Mar 25, 2020 | Issued |
Array
(
[id] => 16837994
[patent_doc_number] => 20210146006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => COMPOSITE CONTAINING COLLAGEN AND ELASTIN AS A DERMAL EXPANDER AND TISSUE FILLER
[patent_app_type] => utility
[patent_app_number] => 16/814613
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814613
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/814613 | COMPOSITE CONTAINING COLLAGEN AND ELASTIN AS A DERMAL EXPANDER AND TISSUE FILLER | Mar 9, 2020 | Abandoned |
Array
(
[id] => 17306340
[patent_doc_number] => 11207423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
[patent_app_type] => utility
[patent_app_number] => 16/814567
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20192
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814567
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/814567 | Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs | Mar 9, 2020 | Issued |
Array
(
[id] => 17769375
[patent_doc_number] => 11401303
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof
[patent_app_type] => utility
[patent_app_number] => 17/310121
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 38
[patent_no_of_words] => 8774
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310121 | Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof | Mar 2, 2020 | Issued |
Array
(
[id] => 16296294
[patent_doc_number] => 20200282017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => COMPOSITIONS AND METHOD FOR REDUCING VIRULENCE OF MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 16/807792
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807792
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/807792 | Compositions and method for reducing virulence of microorganisms | Mar 2, 2020 | Issued |
Array
(
[id] => 17627263
[patent_doc_number] => 20220162278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY
[patent_app_type] => utility
[patent_app_number] => 17/433009
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433009 | CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY | Feb 26, 2020 | Pending |
Array
(
[id] => 16091155
[patent_doc_number] => 20200199564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 16/787456
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/787456 | FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION | Feb 10, 2020 | Abandoned |
Array
(
[id] => 16598117
[patent_doc_number] => 20210024648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => MODIFIED PSEUDOMONAS EXOTOXIN A
[patent_app_type] => utility
[patent_app_number] => 16/785911
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/785911 | MODIFIED PSEUDOMONAS EXOTOXIN A | Feb 9, 2020 | Abandoned |
Array
(
[id] => 16053201
[patent_doc_number] => 20200188455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => TUBE FEED FORMULATIONS AND METHODS FOR USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/782336
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/782336 | TUBE FEED FORMULATIONS AND METHODS FOR USING SAME | Feb 4, 2020 | Pending |